Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis

Documenti analoghi

• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by <it>Candida albicans</it>: a multivariate analysis of factors associated with improved outcome
  di: Reisman Arlene L, et al.
  Pubblicazione: (2011-09-01)
• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
  di: Reboli, Annette C, et al.
  Pubblicazione: (2011)
• Anidulafungin compared with fluconazole therapy in critically ill patients
  di: Kett, DH, et al.
  Pubblicazione: (2010)
• Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
  di: Vazquez, Jose, et al.
  Pubblicazione: (2014)
• Pharmacokinetics of Anidulafungin in Critically Ill Patients with Candidemia/Invasive Candidiasis
  di: Liu, Ping, et al.
  Pubblicazione: (2013)